Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387515900> ?p ?o ?g. }
- W4387515900 endingPage "4072" @default.
- W4387515900 startingPage "4057" @default.
- W4387515900 abstract "Osteosarcoma (OS) is the most frequent primary bone cancer, which is mainly suffered by children and young adults. While the current surgical treatment combined with chemotherapy is effective for the early stage of OS, advanced OS preferentially metastasizes to the lung and is difficult to treat. Here, we examined the efficacy of ten anti-OS peptide candidates from a trypsin-digested conditioned medium that was derived from the secretome of induced tumor-suppressing cells (iTSCs). Using OS cell lines, the antitumor capabilities of the peptide candidates were evaluated by assaying the alterations in metabolic activities, proliferation, motility, and invasion of OS cells. Among ten candidates, peptide P05 (ADDGRPFPQVIK), a fragment of aldolase A (ALDOA), presented the most potent OS-suppressing capabilities. Its efficacy was additive with standard-of-care chemotherapeutic agents such as cisplatin and doxorubicin, and it downregulated oncoproteins such as epidermal growth factor receptor (EGFR), Snail, and Src in OS cells. Interestingly, P05 did not present inhibitory effects on non-OS skeletal cells such as mesenchymal stem cells and osteoblast cells. Collectively, this study demonstrated that iTSC-derived secretomes may provide a source for identifying anticancer peptides, and P05 may warrant further evaluations for the treatment of OS." @default.
- W4387515900 created "2023-10-12" @default.
- W4387515900 creator A5006404776 @default.
- W4387515900 creator A5008017308 @default.
- W4387515900 creator A5014864428 @default.
- W4387515900 creator A5021823990 @default.
- W4387515900 creator A5024196036 @default.
- W4387515900 creator A5029393424 @default.
- W4387515900 creator A5030457373 @default.
- W4387515900 creator A5034416233 @default.
- W4387515900 creator A5048399617 @default.
- W4387515900 creator A5059830381 @default.
- W4387515900 creator A5061304782 @default.
- W4387515900 creator A5081940051 @default.
- W4387515900 creator A5082044378 @default.
- W4387515900 creator A5089265440 @default.
- W4387515900 date "2023-01-01" @default.
- W4387515900 modified "2023-10-13" @default.
- W4387515900 title "Anticancer peptides from induced tumor-suppressing cells for inhibiting osteosarcoma cells." @default.
- W4387515900 cites W1975005064 @default.
- W4387515900 cites W1990399973 @default.
- W4387515900 cites W2046524941 @default.
- W4387515900 cites W2131078803 @default.
- W4387515900 cites W2138977668 @default.
- W4387515900 cites W2142046859 @default.
- W4387515900 cites W2339899799 @default.
- W4387515900 cites W2522803584 @default.
- W4387515900 cites W2598922467 @default.
- W4387515900 cites W2775185528 @default.
- W4387515900 cites W2938365940 @default.
- W4387515900 cites W2976804353 @default.
- W4387515900 cites W3029878681 @default.
- W4387515900 cites W3036713553 @default.
- W4387515900 cites W3044216590 @default.
- W4387515900 cites W3080349534 @default.
- W4387515900 cites W3093706924 @default.
- W4387515900 cites W3117860829 @default.
- W4387515900 cites W3118342167 @default.
- W4387515900 cites W3118447272 @default.
- W4387515900 cites W3120853873 @default.
- W4387515900 cites W3133945326 @default.
- W4387515900 cites W3137354412 @default.
- W4387515900 cites W3159932654 @default.
- W4387515900 cites W3167266199 @default.
- W4387515900 cites W3176738485 @default.
- W4387515900 cites W3176873949 @default.
- W4387515900 cites W3178414285 @default.
- W4387515900 cites W3182969438 @default.
- W4387515900 cites W3186281007 @default.
- W4387515900 cites W3205608144 @default.
- W4387515900 cites W4200492751 @default.
- W4387515900 cites W4205816062 @default.
- W4387515900 cites W4205823500 @default.
- W4387515900 cites W4206024274 @default.
- W4387515900 cites W4280554153 @default.
- W4387515900 cites W4282583463 @default.
- W4387515900 cites W4283271625 @default.
- W4387515900 cites W4289450595 @default.
- W4387515900 cites W4289525677 @default.
- W4387515900 cites W4289731436 @default.
- W4387515900 cites W4293770401 @default.
- W4387515900 cites W4295720418 @default.
- W4387515900 cites W4309461288 @default.
- W4387515900 cites W4311679543 @default.
- W4387515900 cites W4311788484 @default.
- W4387515900 cites W4312217681 @default.
- W4387515900 cites W4315871679 @default.
- W4387515900 cites W4317207796 @default.
- W4387515900 cites W4317886222 @default.
- W4387515900 cites W4328049082 @default.
- W4387515900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37818062" @default.
- W4387515900 hasPublicationYear "2023" @default.
- W4387515900 type Work @default.
- W4387515900 citedByCount "0" @default.
- W4387515900 crossrefType "journal-article" @default.
- W4387515900 hasAuthorship W4387515900A5006404776 @default.
- W4387515900 hasAuthorship W4387515900A5008017308 @default.
- W4387515900 hasAuthorship W4387515900A5014864428 @default.
- W4387515900 hasAuthorship W4387515900A5021823990 @default.
- W4387515900 hasAuthorship W4387515900A5024196036 @default.
- W4387515900 hasAuthorship W4387515900A5029393424 @default.
- W4387515900 hasAuthorship W4387515900A5030457373 @default.
- W4387515900 hasAuthorship W4387515900A5034416233 @default.
- W4387515900 hasAuthorship W4387515900A5048399617 @default.
- W4387515900 hasAuthorship W4387515900A5059830381 @default.
- W4387515900 hasAuthorship W4387515900A5061304782 @default.
- W4387515900 hasAuthorship W4387515900A5081940051 @default.
- W4387515900 hasAuthorship W4387515900A5082044378 @default.
- W4387515900 hasAuthorship W4387515900A5089265440 @default.
- W4387515900 hasConcept C121608353 @default.
- W4387515900 hasConcept C126322002 @default.
- W4387515900 hasConcept C142724271 @default.
- W4387515900 hasConcept C185592680 @default.
- W4387515900 hasConcept C198826908 @default.
- W4387515900 hasConcept C2776694085 @default.
- W4387515900 hasConcept C2777760704 @default.
- W4387515900 hasConcept C2778239845 @default.
- W4387515900 hasConcept C2781303535 @default.